GUIDE: Reporting Template_Tuberculosis Narrative Report section Contract Number Project Title Contract Period Reporting Period Reporting Date (dd/mm/yyyy) explanation project start and end date in (DD/MM/YYYY) format 1. GENERAL SITUATION (For this reporting period) A brief overview describing developments & main experiences, and a discussion on any significant or unexpected changes or events relevant to your programme (No more than 400 words) 2. GOOD PRACTICES AND CHALLENGES/CONSTRAINTS (For this reporting period) A note on what did and did not work well, also specific difficulties encountered and what strategies were developed to adjust implementation 2.1 GOOD PRACTICES: (Key achievements and A list on key achievements and related approaches which worked for achievements. approaches that worked well) 2.2 CHALLENGES/CONSTRAINTS/DIFFICULTIES: A list on difficulties encountered and strategies/actions undertaken to address these issues. 3. PRESSING ISSUES (For this reporting period) The actions which are needed from 3MDG Fund to help your programme/your work. Annex B_Core Indicators section Disease Reporting period explanation Indicator The indicators are aligned with project logical framework. Target Target figures are pre-filled in the relevant cells. Those figures (number or %)are taken from latest version of Logical Frame sheet submitted priorily and approved by 3MDG FMO. Achievement The achieved figures are needed to fill under this column. The information for age and sex disaggregation are requested for relevant indicators. % Achieved 3MDG added the formula to calculate percentage of achievement against the targets. Reasons for programmatic deviation and any other A note on why under-achieve or over-achieve during the reporting period. comments Annex C_Achieved by township Section Disease Reporting period State/Region and Township Cases of bacteriologically confirmed DR TB who began second line treatment MDR-TB patients receiving socioeconomic support DOT providers received training and provide DOT for MDR TB patients explanation The township list is same as proposed township area and 3MDG will fill this information according to signed description of action document. The number mentioned in this annex C townships must be consistent with Annex B achieved results. How many confirmed MDR TB cases are under second line treatment in this township? Fill out only the achievement figures for this reporting period How many MDR TB patients are receiving socioeconomic support in this township? Fill out only the achievement figures for this reporting period How many DOT providers are trained and providing DOT for MDR TB patients in this township? Fill out only the achievement figures for this reporting period Version V02_TB, July 2014. 1 MDRTB-Reporting-Template-Master
3MDG FUND TECHNICAL REPORT Contract Number Project Title Contract Period Reporting Period Reporting Date (dd/mm/yyyy) From: To: 1. GENERAL SITUATION (For this reporting period) A brief overview describing developments & main experiences, and a discussion on any significant or unexpected changes or events relevant to your programme (No more than 400 words) 1.1 Main Experiences (No more than 200 words) 1.2 Significant and/or unexpected changes (No more than 200 words) 2. GOOD PRACTICES AND CHALLENGES/CONSTRAINTS (For this reporting period) (A note on what did and did not work well, also specific difficulties encountered and what strategies were developed to adjust implementation) 2.1 GOOD PRACTICES: (Key achievements and approaches that worked well) Sr. 1 2 3 4 5 6 7 8 9 10 Key Achievements Approaches (Why it worked?) Version V02_TB, July 2014. 2 MDRTB-Reporting-Template-Master
2.2 CHALLENGES/CONSTRAINTS/DIFFICULTIES: (Difficulties encountered and strategies/actions undertaken to address these issues) Sr. 1 Challenges/Constraints/Difficulties Actions taken Additional comments 2 3 4 5 6 7 8 9 10 3. PRESSING ISSUES (For this reporting period) What actions are needed from the 3MDG Fund to help your work? Version V02_TB, July 2014. 3 MDRTB-Reporting-Template-Master
Annex B: Core Indicators (Fill out only those which are relevant for your project) Disease Reporting period 0 Tuberculosis 0 ID INDICATOR 1 Prevalence of MDR-TB among new smear-positive TB patients TARGET ACHIEVEMENT Total Total TARGET Male Female Male Female Achieved % Achieved Reasons for programmatic deviation and any other comments 2 Treatment success rate among MDR-TB cases (% of confirmed MDR-TB successfully treated) 3 No. of MDR-TB cases notified to the national TB program 4 5 6 7 8 No. of cases of bacteriologically confirmed DR TB (RR and/or MDR) who began second line treatment No. of MDR TB cases successfully treated among the bacteriologically confirmed MDR TB cases registered during a specified period No. of MDR-TB cases on MDR-TB treatment regimen with an outcome of "cured" No. of MDR-TB cases on MDR-TB treatment regimen with an outcome of "defaulted" No. of MDR-TB patients receiving socioeconomic support (disaggregated by sex) 9 No. of MDR-TB patients receiving allowance for transport for diagnosis and treatment (disaggregated by sex) 10 Number of physicians, township medical officers and TB coordinators (training of trainers) trained on MDR-TB management 11 Number of basic health staff trained on MDR-TB management 12 13 14 Number of DOT providers received training and provide DOT for MDR TB patients No. of MDR-TB patients receiving DOT through volunteers (disaggregated by sex) Provide treatment, socioeconomic support and travel allowances to MDR-TB patients treated with pilot short course DRTB treatment for both HIV co-infected and non-hiv DRTB Patients No. of cases of bacteriologically confirmed DR TB (RR and/or MDR) who began second line treatment (pilot short course) Version V02_TB, July 2014. 4 MDRTB-Reporting-Template-Master
15 No. of MDR TB cases successfully treated among the bacteriologically confirmed MDR TB cases registered during a specified period (pilot short course) 16 No. of MDR-TB patients receiving socioeconomic support (disaggregated by sex) (pilot short course) 17 No. of MDR-TB patients receiving allowance for transport for diagnosis and treatment (disaggregated by sex) (pilot short course) * Comments (if any) on the figures reported: Version V02_TB, July 2014. 5 MDRTB-Reporting-Template-Master
Annex C: Township wise Report (Fill out only the achievement figures for this reporting period) Disease Reporting period: Tuberculosis 0 0 Sr. State/Region Township 1 Cases of bacteriologically confirmed DR TB who began second line treatment MDR-TB patients receiving socioeconomic support DOT providers received training and provide DOT for MDR TB patients Remark 2 3 4 5 6 7 8 9 10 Version V02_TB, July 2014. 6 MDRTB-Reporting-Template-Master
ACCOUNTABILITY, EQUITY AND INCLUSION (AEI) AND CONFLICT SENSITIVITY (CS) REPORT 0 Township Contract Number 0 Contract Period From: 0-Jan-00 To: 0-Jan-00 Reporting Period 0 00/01/1900 Reporting Date (dd/mm/yyyy) Do you have an AEI Focal Point? For how long? 1 KEY AEI & CS ACTIVITIES implemented by the AEI Focal Point or the Organization Please provide details in the below table including key achievements and challenges. (for this reporting period) No Description Brief comments on implementation Achievements Challenges 1.1 Organizational Commitments on AEI & CS (e.g. AEI and CS related policies including gender mainstreaming, staff code of conduct, written principles of stakeholder inclusion and nondiscrimination, etc ) 1.2 Staff Capacity Building (e.g. six monthly capacity building plan on AEI + CS, etc...) 1.3 1.4 Sharing Information (e.g. quarterly meetings or other methods to share appropriate information about the organization and its activities with all relevant stakeholders including beneficiaries, etc...) Participation (e.g.ongoing comprehensive stakeholder participation at different stages of the project, examples and records that input is affecting programme/project decisions, etc ) 1.5 Learning and Continual Improvement (e.g. regular monitoring of progress on AEI and CS issues and learning/reflection based on results, such as workshops, etc ) 1.6 Social Inclusion (e.g. organisation has ongoing routine consultation meetings with CSOs and all key stakeholders, etc...) 1.7 Project Community Feedback (number) (Total number of feedback received and responded to. How did you respond and when?) 1.8 Project Community Feedback (issues) (Identify the top five issues raised through feedback mechanism e.g. relevant to project, organization, advocacy to relevant authority, 3MDG Fund and others) Version V01_AEI, July 2014. 7 MDRTB-Reporting-Template-Master
1.9 Strengthening local partner capacity (if you have local partner(s), please explain how you have strengthened their capacities in the past six months) 2. KEY LESSONS LEARNED (for this reporting period) Please provide AEI & CS key lessons learned (No more than 500 words) Version V01_AEI, July 2014. 8 MDRTB-Reporting-Template-Master